Filing Details

Accession Number:
0001177648-19-000032
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-12 16:51:09
Reporting Period:
2019-03-11
Accepted Time:
2019-03-12 16:51:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1177648 Enanta Pharmaceuticals Inc ENTA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1225503 A L Bruce Carter C/O Enanta Pharmaceuticals, Inc.
500 Arsenal Street
Watertown MA 02472
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-03-11 1,546 $23.40 1,546 No 4 M Direct
Common Stock Disposition 2019-03-11 1,546 $99.16 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-03-11 1,546 $0.00 1,546 $23.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-11-22 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in August 2018.
  2. 100% of the shares subject to the option are fully vested and exercisable.